Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pharmacielo Ltd V.PCLO

Alternate Symbol(s):  PCLOF

Financial Services Healthcare Asset Management
PharmaCielo Ltd. is a Canada-based company with a focus on ethical and sustainable processing and supplying of all natural, pharmaceutical-grade medical cannabis products to channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all... see more

Recent & Breaking News (TSXV:PCLO)

PharmaCielo Provides Update on Latin American Sales Progress and Non-Brokered Private Placement of Debenture Units

PR Newswire February 4, 2022

PharmaCielo Completes Initial Tranche of Non-Brokered Private Placement of Debenture Units

PR Newswire December 31, 2021

PharmaCielo Announces $15.0 Million Non-Brokered Private Placement of Debenture Units

PR Newswire December 22, 2021

PharmaCielo Announces Q3-2021 Financial Results

PR Newswire November 29, 2021

PharmaCielo Receives Confirmation of Colombian Phytotherapeutics GMP Certification

GlobeNewswire September 14, 2021

PharmaCielo Announces the Appointment of Cannabis Industry Veterans Bob DeGabrielle and Will Nicholas to the Company's Board

PR Newswire September 1, 2021

PharmaCielo Announces Q2-2021 Financial Results and Appointment of Bill Petron as CEO

PR Newswire August 20, 2021

PharmaCielo Signs Sales Agreement and Makes Initial Commercial Sale to Pharmaceutical Player in Brazil

PR Newswire August 4, 2021

PharmaCielo Welcomes Colombian Government's New Cannabis Decree

PR Newswire July 26, 2021

PharmaCielo to Participate in the Cantor Fitzgerald International Cannabis Forum

Canada NewsWire June 23, 2021

PharmaCielo Makes Initial Shipment to Canadian Life Sciences Company

Canada NewsWire June 15, 2021

PharmaCielo Announces Election of Directors - Welcomes Bill Petron, a Global Operations and Cannabis Veteran, as Chairman of the Board

Canada NewsWire June 10, 2021

PharmaCielo Appoints Experienced Cannabis Executive Ian D. Atacan as Chief Financial Officer

Canada NewsWire May 31, 2021

PharmaCielo Announces Financial Results for the First Quarter Ended March 31, 2021

Canada NewsWire May 31, 2021

PharmaCielo Announces Bill Petron, a Global Operations and Cannabis Veteran, to Stand for Election as a Nominee for Chairman of the Board

Canada NewsWire May 13, 2021

PharmaCielo Provides Update on Global GMP Compliance Process

Canada NewsWire May 5, 2021

PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2020

Canada NewsWire May 3, 2021

PharmaCielo Makes Initial Shipments to two Brazilian Customers

Canada NewsWire April 26, 2021

PharmaCielo Announces Closing of Overnight Marketed Equity Offering for Gross Proceeds of $13.5 Million

Canada NewsWire April 7, 2021

PharmaCielo Provides Corporate Update

Canada NewsWire March 31, 2021